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Abstract
Introduction: New therapies and treatment protocols have led to improved survival rates in
many cancers. The improved rates are such that patients are now living long enough to experience
some negative long-term side effects of the initial therapy.
Case presentation: We report the case of a 65-year-old Caucasian woman who presented with
a rare case of pseudotumoral radionecrosis, a late radiation-induced injury, after combined surgical
and cobalt radiation therapy for the treatment of adenocarcinoma of the right breast. The patient
underwent resection of this benign, yet progressively growing and painful tumor. A cosmetically
satisfying result was achieved by reconstruction of the thoracic wall with a polypropylene mesh and
a latissimus dorsi muscle flap.
Conclusion: With improved overall survival, new management strategies for late side effects of
therapy are becoming of crucial importance for affected patients. In the future, improving toxicity-
free survival will be as important as achieving disease-free survival or local tumor control.
Introduction
With the increasing number of long-term survivors who
have been treated with newer anticancer therapy strate-
gies, we encounter increasing numbers of sequelae from
earlier therapeutic approaches. These long-term side
effects are an important factor in the patient's quality of
life, both psychologically and somatically, and must be
addressed in the treatment of the underlying disease.
Radiation-induced fibroatrophy (RIF) is a rare late sequela
of high-dose radiation therapy. It is localized to the radia-
tion field and is usually irreversible. The pathologic man-
ifestation of this entity can be limited to skin dryness,
hyperpigmentation or telangiectasia. This superficial
damage, however, may also be combined with underlying
fibronecrotic lesions affecting the pleura and lungs result-
ing in pulmonary fibrosis, neurological disorders second-
ary to the development of perineural fibrosis, or
spontaneous rib fractures due to osteoradionecrosis [1-3].
We report the excellent cosmetic and functional results
after surgical treatment in a particular clinical setting of
pseudotumoral radionecrosis as a late radiation-induced
injury after initial anticancer treatment.
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Case presentation
We report the case of a 65-year-old Caucasian woman
who presented with a subcutaneous inflammatory tumor
of the right breast, which had been progressively growing
over a period of 10 years (Figure 1). The patient had a past
history of a multifocal adenocarcinoma of the right breast,
which was resected 23 years earlier. Further treatment
included chemotherapy with six cycles of fluorouracil,
doxorubicin and cyclophosphamide in combination with
cobalt radiation with a total dose of 60 Gy, followed by
tamoxifen for a total of 12 years. The first local signs were
observed seven years after the radiation treatment with the
loss of irradiated skin elasticity followed by increasing
induration and telangiectasia. Over the 10 years before
presentation, the mass had significantly increased in size
and become increasingly painful, restricting the patient
psychologically and functionally in her daily activities.
The patient's other past medical history included high
blood pressure and hypercholesterolemia. Her only addi-
tional surgery was an appendectomy during childhood.
Diagnostic work-up (bone scintigraphy, abdominal ultra-
sound, thoracic computed tomography (CT) scan)
revealed no local or distant metastases (Figure 2). As there
was no suspicion for a progressive malignant disease, we
did not perform a pre-operative biopsy. We offered the
patient resection of the thoracic wall, reconstruction by a
Premilene® mesh and switching of an ipsilateral latissimus
dorsi muscle flap. Intra-operatively, we observed multiple
retromammarial adhesions without macroscopic tumor
infiltration. Pathological fractures of costae 3/4/5 were
also observed. The tumor could be removed in its entirety.
Reconstruction of the thoracic wall was performed with a
double layer polypropylene mesh (Premilene®, Braun,
Melsungen), fixed with Ethibond® (Ethicon, Norderstedt)
sutures. A flap of the latissimus dorsi muscle was then
mobilized and switched to the thoracic wall. The muscle
was fixed circularly, subcutaneously and cutaneously.
Two thoracic drains were placed (Figure 3). The whole
operation time was 210 minutes, and blood loss
remained minimal at 50 ml.
The thoracic drains were removed on postoperative days 4
and 8, and the patient left our institution on postoperative
day 18. Microscopic examination of the resected specimen
showed a wide, almost scarred, radionecrosis and fibrosis
of fat, muscle and bone (Figure 4). Also noted were
extended dystrophic calcifications corresponding to a
radiation-induced vasculopathy. Histologically, there was
no evidence of malignancy. Within a follow-up of 14
months, the cosmetic result remained satisfactory without
any disturbance in healing.
Discussion
In the majority of cases, cancer is an aggressive disease
which is often fatal and requires consequential therapeu-
tic approaches with agents that provide a narrow thera-
peutic window. The toxicity of the therapy and the
acceptable risk of complications have to be balanced
against the risk of recurrence of the malignancy. Radiation
therapy has been one of the pillars of cancer therapy for
many years. Many technological advances have been
made to improve radiation delivery to the targeted area
while reducing damage to the surrounding normal tissue.
However, with improving survival of our patients, we are
now able to observe the long-term effects of earlier thera-
pies, which, at the time they were applied, were in accord-
ance with the best knowledge available.
The spectrum of late radiation-induced injuries is quite
heterogeneous but the injuries are usually benign. They
may manifest themselves as breast edema, fibrosis, tel-
angiectasia, pulmonary fibrosis, chronic ulceration, rib
fractures, fat necrosis or osteonecrosis [4]. The main dif-
ferential diagnosis is malignant radiation-induced sar-
coma (RIS), which has a very poor prognosis [5].
Fajardo differentiates between epithelial and/or parenchy-
mal, stromal and vascular lesions as delayed injuries from
ionizing radiation [6]. Epithelial and/or parenchymal
lesions include atrophy, necrosis, metaplasia, cellular aty-
pia, dysplasia, and neoplasia. Fibrosis, fibrinous exudates,
necrosis and atypical fibroblasts are considered to be com-
mon stromal lesions. Vascular lesions affect the microves-
sels producing lethal and sublethal damage to the
endothelial cells, with capillary rupture or thrombosis,
and may present as telangiectasia [6].
Pre- and postoperative macroscopic presentation Figure 1
Pre- and postoperative macroscopic presentation. 
(A) Calcific subcutaneous, painful, progressively growing 
tumor on the right breast 23 years after 60 Gy cobalt radia-
tion before the corrective operation. (B) Post-corrective 
surgery: after reconstruction of the thoracic wall with a dou-
ble layer polypropylene mesh and switching of a flap of latis-
simus dorsi muscle to the thoracic wall.Journal of Medical Case Reports 2009, 3:71 http://www.jmedicalcasereports.com/content/3/1/71
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These changes may occur in any organ. The incidences of
complications involving tissues that have a slow turnover
increase with time after radiation while most acute reac-
tions are observed in epithelial tissues. Therefore, a long
follow-up is necessary in order to fully understand the tox-
icity of the treatment. The increasing number of long-term
survivors allows us to observe these important late side
effects more frequently.
In the future, the ability to provide toxicity-free survival
may be as important an outcome as achieving a disease-
free survival or local tumor control [7]. Perception of a
long-term injury from prior treatment as a burden may be
very different for the patient and the doctor, in particular,
if the morbidity is irreversible, protracted, uncontrollable,
painful or socially disabling.
In order to evaluate the most effective therapeutic strategy
and to permit quantification of late effects on normal tis-
sue, all patients should be systematically monitored using
a scoring system such as the LENT-SOMA (late effects nor-
mal tissues - subjective, objective, management, and ana-
lytic) scale, as proposed by The European Organization
Pre-operative imaging studies of the tumor Figure 2
Pre-operative imaging studies of the tumor. Computed tomographic scan of the thorax (A) and respective 3-D image 
(B) exhibiting a large area of costal and muscular radionecrosis. The pleura was not affected.
Intra-operative situs and steps in the surgical procedure Figure 3
Intra-operative situs and steps in the surgical procedure. (A) Operative field; (B) placement of two thoracic drains 
after resection of the tumor; (C, D) reconstruction of the thoracic wall with a double layer polypropylene mesh; (E) mobiliza-
tion and switching of the latissimus dorsi flap to the thoracic wall; (F) wound closure.Journal of Medical Case Reports 2009, 3:71 http://www.jmedicalcasereports.com/content/3/1/71
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for Research and Treatment of Cancer and the Radiation
Therapy Oncology Group (EORTC/RTOG) [5,7,8].
A variety of conservative strategies have been evaluated in
order to manage radiation-induced fibroatrophic proc-
esses. Treatment approaches include superoxide dis-
mutase or combined pentoxifylline-tocopherol
application, underlining the importance of an antioxidant
pathway [9,10]. However, in our particular case, surgery
was unavoidable. As the possibility of local recurrence or
persistence of the primary malignant tumor within the
radiated tissue exists, an adequate pre-operative diagnos-
tic work-up must be done before planning a resection
and/or reconstructive surgical strategy [11,12].
We report the excellent surgical result of performing an
ablatio mammae with resection of the thoracic wall, and
reconstruction with a synthetic mesh and a latissimus
dorsi muscle flap.
In our patient, the symptomatic pain in the right chest
decreased minimally postoperatively. This may have
resulted from the surgical trauma after the radical surgery,
which was performed in order to reduce as much of the
irradiated tissue as possible. Subjectively, the patient
reported high satisfaction with the cosmetic and func-
tional outcome. This corresponds to the reported phe-
nomenon that patients evaluate operative results less
critically [13,14].
Conclusion
Radiation-induced long-term side effects may have a
benign or malign nature. The aggressive and poor prog-
nostic nature of RIS is the main malignant differential
diagnosis for late radiation-induced alterations. Late radi-
ation-induced fibroatrophy (RIF) as a benign adverse
event is a rare, irreversible and unavoidable damage after
radiotherapy. It may adversely affect the functional and
esthetic outcome of patients. Besides conservative treat-
ment options including superoxide dismutase or com-
bined pentoxifylline-tocopherol, secondary radical
Histological characteristics of the specimen Figure 4
Histological characteristics of the specimen. Wide, almost scarred, radionecrosis and fibrosis of muscle, fat and bone, 
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surgery with exeresis of the necrotic defect and flap recon-
struction is the usual treatment in the case of combined
superficial RIF with spontaneous or trauma-induced
fibronecrotic lesions of the underlying irradiated tissue
and bones. It permits excellent cosmetic and functional
results.
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